<DOC>
	<DOC>NCT01092143</DOC>
	<brief_summary>This is a 6 week study to investigate the effectiveness and safety of BI 671800 ED in patients with asthma who do not take inhaled corticosteroids.</brief_summary>
	<brief_title>BI 671800 ED in Steroid-naive Asthmatic Patients</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Inclusion criteria: 1. Signed informed consent consistent with ICHGCP 2. Three month history of reversible (12% with 200 mL) asthma (according to GINA) with following spirometry at randomization: FEV1 60%85%. 3. No ICS previous 3 months prior to screening. 4. Diagnosis of asthma prior to 40 years. 5. ACQ at least 1.5 at randomization. 6. Male or female, 18 to 65 years. 7. Nonsmokers or exsmokers ( less than 10 pack year history) with negative cotinine screen. 8. Able to perform PFT Exclusion criteria: 1. Significant diseases other than asthma or allergic rhinitis. 2. Hepatic transaminases or total bilirubin greater than 1.5 ULN. 3. Hospitalizations for asthma or asthma related intubation within 3 months. 4. Uncontrolled asthma. 5. Respiratory tract infection or exacerbation within 4 weeks. 6. FEV1 less than 40%, more than 12 puffs of SABA on more than two consecutive days or asthma exacerbation during the runin period. 7. Participation in another interventional study. 8. Pregnant or nursing women. 9. Women of child bearing potential nor using appropriate methods of birth control as defined by protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>